HIMS Commentator
TSLL Gain Hunter(Video) Hims vs Noom vs Ro: Who Will Win the Telemedicine War?
Episode 61 of the "Hims House" podcast featured host Jonathan Stern interviewing Geoff Cook, CEO of Noom. The core content of the video revolves around a major recent move by Noom: the acquisition of the 503A compounding pharmacy Tailor Made Compounding. This interview delves into the future of the telemedicine industry, regulatory trends for GLP-1 drugs, and the potential of the "healthy aging" market.$Defiance Daily Target 2X Long HIMS ETF(HIMZ.US) $Hims & Hers Health(HIMS.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
